Reuters logo
BRIEF-Novo Nordisk says semaglutide diabetes drug brand name will be Ozempic
November 21, 2017 / 10:25 AM / 23 days ago

BRIEF-Novo Nordisk says semaglutide diabetes drug brand name will be Ozempic

Nov 21 (Reuters) - NOVO NORDISK CHIEF EXECUTIVE LARS FRUERGAARD JORGENSEN SAID AT THE FIRM‘S CAPITAL MARKETS DAY:

* GLP-1 SEMAGLUTIDE DRUG BRAND NAME FOR DIABETES TREATMENT WILL BE ‘OZEMPIC’ FURTHER COMPANY COVERAGE: (Reporting by Stine Jacobsen)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below